1. EP1168 The influence of obesity on tumor recurrence in vulvar cancer patients. (1st November 2019) Authors: Klapdor, R; Hillemanns, P; Wölber, L; Jückstock, J; Hilpert, F; de Gregorio, N; Hasenburg, A; Sehouli, J; Fürst, ST; Strauß, HG; Baumann, K; Thiel, F; Mustea, A; Meier, W; Harter, P; Wimberger, P; Hanker, L; Schmalfeldt, B; Mahner, S Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 4 Page Start: A605 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. LBA10Phase III PAOLA-1/ENGOT-ov25 trial: Olaparib plus bevacizumab (bev) as maintenance therapy in patients (pts) with newly diagnosed, advanced ovarian cancer (OC) treated with platinum-based chemotherapy (PCh) plus bev. (24th November 2019) Authors: Fujiwara, K; Harter, P; Leary, A; Perol, D; Pignata, S; González-Martín, A; Petru, E; van Nieuwenhuysen, E; Colombo, N; Mäenpää, J; Selle, F; de Gregorio, N; Lorusso, D; Guerra Alia, E M; Lefeuvre-Plesse, C; Buderath, P; Lortholary, A; Burges, A; Pujade-Lauraine, E; Ray-Coquard, I L Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P193 p53 and p16 expression profiles identify three prognostically subgroups in vulvar cancer: a TMA based study by the AGO-CaRE-translational study group. (1st November 2019) Authors: Wölber, L; Prieske, K; Eulenburg, C; de Gregorio, N; Klapdor, R; Kalder, M; Braicu, I; Fuerst, S; Klar, M; Strauss, H-G; Mehlhorn, G; Meier, W; Ignatov, A; Mustea, A; Jueckstock, J; Schmidt, G; Bauerschlag, D; Hellriegel, M; Canzler, U; Luyten, A Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 4 Page Start: A172 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗